About Hyalex Orthopaedics
Hyalex Orthopaedics is a Boston-based medical device start-up focused on developing and commercializing new products that feature HYALEX™ materials technology. Unlike other polymers, synthetic HYALEX material has the unique capability of maintaining low friction and low wear under the high loads encountered in human joints. HYALEX Orthopaedics' products are in the development stage and have not been approved for use in humans by any regulatory agency.
Founders: David Myung and Lampros Kourtis
CEO: Mira Sahney
4 articles with Hyalex Orthopaedics
Hyalex Orthopaedics, synthetic cartilage company, adds new funding; expanding Series A total to $33MM
Brad Vale, PhD, DVM General Partner at Strategic Healthcare Investment Partners, will join the board as part of the financing
Hyalex Orthopaedics launched in May 2017 as a medical device company that intends to advance new products featuring HYALEX technology, a synthetic polymer that mimics cartilage.
BioSpace is proud to present its NextGen "Class of 2018," a list of 20 up-and-coming life science companies in North America that started up no earlier than 2015.